Article
HPV and p53 status as precision determinants of head and neck cancer response to DNA-PKcs…
medRxiv · 2023 · Hayrapetyan, L.; Roth, S. M.; Hovhannisyan, L.; Medo, M.; Quintin, A.; Ott, J.; Albers, J.; Aebersold, D. M.; Zimmer, Y.; Medova, M.
Key facts
| Title | HPV and p53 status as precision determinants of head and neck cancer response to DNA-PKcs inhibition in combination with irradiation |
|---|---|
| First author | Hayrapetyan, L.; Roth, S. M.; Hovhannisyan, L.; Medo, M.; Quintin, A.; Ott, J.; Albers, J.; Aebersold, D. M.; Zimmer, Y.; Medova, M. |
| Journal | medRxiv |
| Published | Nov 6, 2023 |
| DOI | 10.1101/2023.11.02.565300 |
| Devices mentioned | K050963, K810863, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 5 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DBM, KLB and 6 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1